Lupus Landmark Study: A Prospective Registry and Biorepository
Key facts
- Where
- Calgary, Edmonton, Montreal, Québec, Toronto és Winnipeg, KanadaSee the 6 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 110 years old?
Forrás: NCT05934149: ki vehet részt
Where in Kanada
- University Of CalgaryCalgary, KanadaTaking people
- University of Alberta HospitalEdmonton, KanadaTaking people
- McGill University Health CentreMontreal, KanadaTaking people
- CHU de Quebec-Universite LavalQuébec, KanadaTaking people
- University Health Network-Toronto Western HospitalToronto, KanadaTaking people
- University of ManitobaWinnipeg, KanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Lupus Research Alliance
- Trial code
- NCT05934149
- Record updated
- 2026. április 15.
- Original description
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).Read full original descriptionShow less
Lupus Nexus Landmark Study: A Prospective Registry and Biorepository
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
Inclusion: Able to understand and comply with study procedures and voluntarily sign a written informed consent document; Age 18 years or older at the time of enrollment; Fulfill criteria for SLE based on one or more of the following classifications systems:; Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment.
Exclusion: Not able to obtain consent; Not able to meet protocol visit requirements; Pregnant at the time of enrollment.